1. Home
  2. LXFR vs ALT Comparison

LXFR vs ALT Comparison

Compare LXFR & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$14.11

Market Cap

421.4M

Sector

Industrials

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.64

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXFR
ALT
Founded
1898
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.4M
421.5M
IPO Year
2002
2005

Fundamental Metrics

Financial Performance
Metric
LXFR
ALT
Price
$14.11
$2.64
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.67
AVG Volume (30 Days)
101.2K
4.2M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
3.91%
N/A
EPS Growth
N/A
25.37
EPS
0.13
N/A
Revenue
$384,600,000.00
$41,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.01
N/A
P/E Ratio
$47.43
N/A
Revenue Growth
N/A
105.00
52 Week Low
$10.53
$2.73
52 Week High
$16.03
$7.73

Technical Indicators

Market Signals
Indicator
LXFR
ALT
Relative Strength Index (RSI) 69.02 28.55
Support Level $12.29 N/A
Resistance Level $14.83 $4.25
Average True Range (ATR) 0.43 0.17
MACD 0.12 -0.06
Stochastic Oscillator 75.61 3.37

Price Performance

Historical Comparison
LXFR
ALT

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: